Delivery of the Pertactin/P.69 polypeptide of Bordetella pertussis using an attenuated Salmonella typhimurium vaccine strain: expression levels and immune response
- 31 October 1996
- Vol. 14 (14) , 1384-1390
- https://doi.org/10.1016/s0264-410x(96)00036-9
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Expression of LacZ from thehtrA, nirBandgroEpromoters in aSalmonellavaccine strain: Influence of growth in mammalian cellsFEMS Microbiology Letters, 1995
- Expression of the Bordetella pertussis P.69 pertactin adhesin in Escherichia coli: fate of the carboxy-terminal domainMicrobiology, 1994
- Protection of mice against respiratory Bordetella pertussis infection by intranasal immunization with P.69 and FHAVaccine, 1993
- Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus VaccineNature Biotechnology, 1992
- Recombinant P.69/pertactin: immunogenicity and protection of mice against Bordetella pertussis infectionVaccine, 1992
- Construction and characterization of Bordetella pertussis mutants lacking the vir‐regulated P.69 outer membrane proteinMolecular Microbiology, 1991
- Identification and characterization of a protective immunodominant B cell epitope of pertactin (P.69) from Bordetella pertussisEuropean Journal of Immunology, 1991
- Towards third-generation whooping cough vaccinesTrends in Biotechnology, 1991
- Characterization of the protective capacity and immunogenicity of the 69-kD outer membrane protein of Bordetella pertussis.The Journal of Experimental Medicine, 1989
- The Role of Helper T Cell Products in Mouse B Cell Differentiation and Isotype RegulationImmunological Reviews, 1988